Some Canadian pharmacists are already stocking their shelves with generic versions of semaglutide, more commonly known by the brand name Ozempic, following approval from Health Canada.
While the drugs have already skyrocketed in popularity, specifically for people struggling to shed weight, huge cost savings with generics are expected to lower the barrier even more.
Questions remain however, around whether generics will stack up to Novo Nordisk’s brand name version.
